174 related articles for article (PubMed ID: 32007440)
21. Investigation of two general venous thromboembolism risk-stratification models in predicting venous thromboembolic events in TB patients.
Sharif-Kashani B; Azimi M; Tabarsi P; Sadr M; Shirzadi S
Int J Mycobacteriol; 2022; 11(1):83-87. PubMed ID: 35295028
[TBL] [Abstract][Full Text] [Related]
22. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer.
Garas SN; McAlpine K; Ross J; Carrier M; Bossé D; Yachnin D; Mallick R; Cagiannos I; Morash C; Breau RH; Lavallée LT
Urol Oncol; 2022 Aug; 40(8):381.e1-381.e7. PubMed ID: 35581123
[TBL] [Abstract][Full Text] [Related]
24. The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study.
Overvad TF; Skjøth F; Piazza G; Noble S; Ording AG; Larsen TB; Nielsen PB
J Thromb Haemost; 2022 Dec; 20(12):2921-2929. PubMed ID: 36112135
[TBL] [Abstract][Full Text] [Related]
25. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
Khorana AA; Dalal M; Lin J; Connolly GC
Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
[TBL] [Abstract][Full Text] [Related]
26. Venous Thromboembolic Events Following Major Pelvic and Abdominal Surgeries for Cancer: A Prospective Cohort Study.
Serrano PE; Parpia S; Linkins LA; Elit L; Simunovic M; Ruo L; Bhandari M; Levine M
Ann Surg Oncol; 2018 Oct; 25(11):3214-3221. PubMed ID: 30051364
[TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery.
Rollins KE; Peters CJ; Safranek PM; Ford H; Baglin TP; Hardwick RH
Eur J Surg Oncol; 2011 Dec; 37(12):1072-7. PubMed ID: 21925829
[TBL] [Abstract][Full Text] [Related]
28. Patterns and predictors of thromboembolic events among patients with gastric cancer.
Abdel-Razeq H; Mustafa R; Sharaf B; Al-Tell A; Braik D; Ashouri K; Omari Z; Mansour R; Qarqash J; Shaqboua H; Jaradat S; Al-Qasem K; Bater R
Sci Rep; 2020 Oct; 10(1):18516. PubMed ID: 33116272
[TBL] [Abstract][Full Text] [Related]
29. Venous Thromboembolism During Chemotherapy for Testicular Cancer: A Population-Based Study.
Robinson AG; Wei X; Karim S; Raphael MJ; Bedard PL; Booth CM
Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e188-e193. PubMed ID: 32387044
[TBL] [Abstract][Full Text] [Related]
30. Statins, aspirin and risk of thromboembolic events in ovarian cancer patients.
Shai A; Rennert HS; Rennert G; Sagi S; Leviov M; Lavie O
Gynecol Oncol; 2014 May; 133(2):304-8. PubMed ID: 24631448
[TBL] [Abstract][Full Text] [Related]
31. Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
Ramos JD; Casey MF; Crabb SJ; Bamias A; Harshman LC; Wong YN; Bellmunt J; De Giorgi U; Ladoire S; Powles T; Pal SK; Niegisch G; Recine F; Alva A; Agarwal N; Necchi A; Vaishampayan UN; Rosenberg JE; Galsky MD; Yu EY;
Cancer Med; 2017 Jan; 6(1):186-194. PubMed ID: 28000388
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism in advanced ovarian cancer patients undergoing frontline adjuvant chemotherapy.
Pant A; Liu D; Schink J; Lurain J
Int J Gynecol Cancer; 2014 Jul; 24(6):997-1002. PubMed ID: 24905613
[TBL] [Abstract][Full Text] [Related]
33. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
[TBL] [Abstract][Full Text] [Related]
34. Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
Paffenholz P; Grein K; Heidegger I; Nestler T; Grabbert M; Salem J; Hellmich M; Pfister D; Heidenreich A
World J Urol; 2019 Sep; 37(9):1907-1916. PubMed ID: 30547197
[TBL] [Abstract][Full Text] [Related]
35. Incidence of venous thromboembolic events not related to vascular catheters in a prospective cohort of critically ill children.
Östlund ÅKM; Fläring U; Larsson P; Kaiser S; Vermin L; Frisk T; Dahlberg A; Berner J; Norberg Å; Andersson A
Eur J Pediatr; 2022 Aug; 181(8):3031-3038. PubMed ID: 35652985
[TBL] [Abstract][Full Text] [Related]
36. Venous thromboembolic events in glioblastoma patients: An epidemiological study.
Eisele A; Seystahl K; Rushing EJ; Roth P; Le Rhun E; Weller M; Gramatzki D
Eur J Neurol; 2022 Aug; 29(8):2386-2397. PubMed ID: 35545894
[TBL] [Abstract][Full Text] [Related]
37. Incidence and Clinical Characteristic of Venous Thromboembolism in Gynecologic Oncology Patients attending King Chulalongkorn Memorial Hospital over a 10 Year Period.
Oranratanaphan S; Termrungruanglert W; Khemapech N
Asian Pac J Cancer Prev; 2015; 16(15):6705-9. PubMed ID: 26434898
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.
Gonzalez-Billalabeitia E; Castellano D; Sobrevilla N; Guma J; Hervas D; Luengo MI; Aparicio J; Sanchez-Muñoz A; Mellado B; Saenz A; Valverde C; Fernandez A; Margeli M; Duran I; Fernandez S; Sastre J; Ros S; Maroto P; Manneh R; Cerezuela P; Carmona-Bayonas A; Ayala de la Peña F; Luis Aguilar J; Rivera S; García Del Muro X; Germà-Lluch JR;
J Natl Cancer Inst; 2017 Jan; 109(4):. PubMed ID: 28122896
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
[TBL] [Abstract][Full Text] [Related]
40. Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma.
Vathiotis I; Dimakakos EP; Boura P; Ntineri A; Charpidou A; Gerotziafas G; Syrigos K
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1347-1351. PubMed ID: 29806470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]